Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Clinical efficacy of SB-209670 in hypertensive patients

May 26, 1998

Effects of ACE inhibition and beta-adrenoceptor blockade on intimal hypertrophy in renal Tx

May 26, 1998

Profile of ACE inhibition and antihypertensive effects of zofenopril in volunteers and patients

May 26, 1998

AII blocker Bay-10-6734 prevents abnormal VSMC growth in vitro

May 25, 1998

Warner-Lambert receives marketing rights for YM-087, a vasopressin V1 and V2 receptor antagonist

May 25, 1998

Beneficial cardiovascular effects of estrogen demonstrated in postmenopausal women

May 25, 1998

IRFI-117, an adenosine A1 antagonist for oral or i.v. dosing

May 21, 1998

Yamanouchi and Merck KGaA to codevelop cardiovascular drugs

May 21, 1998

S-Nitrosocaptopril combines NO-donor and ACE-inhibitor effects in a single molecule

May 20, 1998

Bayer reports on new studies of nifedipine

May 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...